InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Bernards Rene. Director active across 1 company, notably Lixte Biotechnology Holdings, INC.. In total, 5 filings have been logged. Split: 5 buys · 0 sell. Total volume traded: €59k. History available since 14 November 2022. The latest transaction was disclosed on 2 October 2023 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Bernards Rene is a declarant linked to Lixte Biotechnology Holdings, INC. (XNAS) as Director. He has 5 filings in total, and across the 5 sampled filings between 2022-11-15 and 2023-10-05, the transactions are acquisitions, with 59449 EUR of buys and 0 EUR of sells.